DRS/A

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

SEC Filing Details

Document Details

Form
Filing Date
Jan 26, 2015
Document Date
Jan 26, 2015
Form Description
mendment to a previously filed DRS
Filing Group
Registration Statements
Company
KemPharm
Issuer
KEMPHARM, INC